An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer

Colon cancer & Colorectal cancer

Last Post by Daniel 3 years ago

2 Posts

2 Users

4 Likes

473 Views

RSS

johan

(@j)

Joined: 5 years ago

Posts: 2074

Topic starter 31/05/2020 6:39 am

"The present study revealed that an ultralow dose of DPI, with no significant systemic toxicity involved, may be an effective way to prevent the occurrence and development of CAC"

https://www.thno.org/v10p6743.htm

Daniel and Daniel reacted

Quote

Topic Tags

diphenyleneiodonium

Daniel

(@daniel)

Admin

Joined: 8 years ago

Posts: 1189

31/05/2020 3:17 pm

Thank you Johan! Very helpful one!

And nice to see your real picture in your profile 🙂 https://www.cancertreatmentsresearch.com/community/profile/johan/

johan and johan reacted

ReplyQuote

54 Forums
966 Topics
6,898 Posts
0 Online
10.1 K Members

Forum Icons: Forum contains no unread posts Forum contains unread posts

Topic Icons: Not Replied Replied Active Hot Sticky Unapproved Solved Private Closed